Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 86-92

  Goh, A ^a   Vathsala, A ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Post transplant; renal cell carcinoma; renal cysts

Indexed keywords

ADULT; ARTICLE; CANCER RISK; DIALYSIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 78650875633     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03303.x     Document Type: Article

References (21)

1. Briggs JD,. Causes of death after renal transplantation. Nephrol Dial Transplant 2001; 16: 1545-1549.
2. Stewart JH, Buccianti G, Agodoa L, et al,. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003; 14: 197-207.
3. Zinna S, Vathsala A, Woo KT,. Spectrum of malignancies in Asian renal allograft recipients. TransplantProc 2000; 32: 1990-1991.
4. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913.
5. Schwarz A, Vatandaslar S, Merkel S, Haller H,. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 750-756.
6. Seow A KW, Chia KS, Shi LM, Lee HP, Shanmugaratnam K,. Trends in Cancer Incidence in Singapore 1968-2002. Singapore Cancer Registry Report 2004; Report No. 6.
7. Li MK, Choy DK, Yip SK,. Renal cell carcinoma in patients with chronic renal failure. Ann Acad Med, Singapore 1999; 28: 512-515.
8. Vathsala A, Chow KY,. Renal transplantation in Singapore. Ann Acad Med, Singapore 2009; 38: 291-299.
9. Belldegrun AS, Klatte T, Shuch B, et al,. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): A benchmark for emerging targeted cancer therapies. Cancer 2008; 113: 2457-2463.
10. Kliem V, Kolditz M, Behrend M, et al,. Risk of renal cell carcinoma after kidney transplantation. Clin Transplant 1997; 11: 255-258.
11. Wong G, Chapman JR, Craig JC,. Cancer screening in renal transplant recipients: What is the evidence? Clin J Am Soc Nephrol 2008; 3 (Suppl 2): S87-S100.
12. Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD,. Renal cell carcinoma of native kidneys: Prospective study of 129 renal transplant patients. J Urol 1997; 158: 42-44.
13. Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH,. Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: A prospective US study. Radiology 1995; 195: 667-671.
14. Chandhoke PS, Torrence RJ, Clayman RV, Rothstein M,. Acquired cystic disease of the kidney: A management dilemma. J Urol 1992; 147: 969-974.
15. Matson MA, Cohen EP,. Acquired cystic kidney disease: Occurrence, prevalence, and renal cancers. Medicine 1990; 69: 217-226.
16. Cheuk W, Lo ES, Chan AK, Chan JK,. Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 2002; 33: 761-765.
17. Ishikawa I, Yuri T, Kitada H, Shinoda A,. Regression of acquired cystic disease of the kidney after successful renal transplantation. Amer J Nephrol 1983; 3: 310-314.
18. Cohen HT, McGovern FJ,. Renal-cell carcinoma. New England J Med 2005; 353: 2477-2490.
19. Maluccio M, Sharma V, Lagman M, et al,. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation 2003; 76: 597-602.
20. Basu A, Contreras AG, Datta D, et al,. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res 2008; 68: 5689-5698.
21. Gutierrez-Dalmau A, Campistol JM,. Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review. Drugs 2007; 67: 1167-1198.